Trial Profile
A Phase II Study of Gefitinib Monotherapy as First-Line Treatment for Elderly Patients with Stage IIIB /IV Adenocarcinoma of the Lung
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Oct 2012
Price :
$35
*
At a glance
- Drugs Gefitinib (Primary)
- Indications Lung cancer
- Focus Therapeutic Use
- 15 Aug 2011 New trial record